The Maudsley Bipolar Disorder Project: The Effect of Medication, Family History, and Duration of Illness on IQ and Memory in Bipolar I Disorder
The DOI matches its Crossref record.
Abstract
Article AbstractBackground: Despite the growing recognition of the importance of cognitive impairment in psychiatric disorders, the effect of clinical factors, such as medication use and family history of affective disorders, on cognition in bipolar I disorder patients still remains unclear. This study examines the contribution of known and potential predictors to both general intellectual function and memory in a representative population of bipolar I disorder patients. Method: Of the 425 patients receiving treatment within a defined catchment area, 63 were identified as having bipolar I disorder. Of these patients, 43 were enrolled in the study and participated in a personal interview by a psychiatrist. All patients were invited to participate in a personal interview by a psychiatrist, and information on family history, past psychiatric history, past and current treatments, duration of illness, and age at onset was collected, in addition to demographic data. Cognitive performance was assessed using the Wechsler Adult Intelligence Scale-Revised, the National Adult Reading Test, and the Wechsler Memory Test III. Results: Forty-three patients with DSM-IV bipolar I disorder were enrolled into the Maudsley Bipolar Disorder Project. Patients on treatment with antipsychotic drugs had a lower current full scale IQ, lower general memory scores, and lower working memory scores. A family history of affective disorders was associated with a higher full scale IQ, but not with either general or working memory measures. Duration of illness was negatively associated with general memory scores, but had no effect on either IQ or working memory measures. Conclusion: Current antipsychotic medication, duration of illness, and family history of affective disorder were the most significant predictors of IQ and memory function in bipolar I disorder patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bourne, C., Aydemir, Ö., Balanzá‐Martínez, V., Bora, E., Brissos, S., Cavanagh, J. T. O., Clark, L., Cubukcuoglu, Z., Dias, V. V., Dittmann, S., et al. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12133 · Cited by 644
Self-citationCognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome
Martínez‐Arán, A., Vieta, E., Colom, F., Torrent, C., Sánchez‐Moreno, J., Reinares, M., Benabarre, A., Goikolea, J., Brugué, E., Daban, C., et al. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00111.x · Cited by 586
Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective
Sheffield, J. M., Karcher, N. R., & Barch, D. M. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9388-2 · Cited by 457
Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder
Lewandowski, K. E., Cohen, B. M., & Öngur, D. (2011) · Psychological Medicine · doi:10.1017/s0033291710001042 · Cited by 336
Versace, A., Almeida, J. R. C., Hassel, S., Walsh, N. D., Novelli, M., Klein, C. R., Kupfer, D. J., & Phillips, M. L. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.9.1041 · Cited by 321
Cognitive impairment in bipolar II disorder
Torrent, C., Martínez-Arán, A., Daban, C., Sánchez-Moreno, J., Comes, M., Goikolea, J. M., Salamero, M., & Vieta, E. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.017269 · Cited by 272
Frangou, S., Donaldson, S., Hadjulis, M., Landau, S., & Goldstein, L. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.056 · Cited by 164
Self-citationHeterogeneity in cognitive functioning among patients with bipolar disorder
Martino, D. J., Strejilevich, S. A., Scápola, M., Igoa, A., Marengo, E., Ais, E. D., & Perinot, L. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.12.232 · Cited by 160
“In addition with clinical variables, other studies reported that exposure to antipsychotic medications (Donaldson et al., 2003; Frangou et al., 2005) or environmental factors as alcohol dependence (van Gorp et al, 1998), infection with herpes simplex virus type 1 (Dickerson et al, 2006), and…”
BackgroundCognition and disability in bipolar disorder: lessons from schizophrenia research
Harvey, P. D., Wingo, A. P., Burdick, K. E., & Baldessarini, R. J. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00831.x · Cited by 159
Mora, E., Portella, M. J., Forcada, I., Vieta, E., & Mur, M. (2013) · Psychological Medicine · doi:10.1017/s0033291712001948 · Cited by 157
“2006) and our sample was not excessively medicated (two or fewer drug classes for most of them), which possibly may have reduced the effect on cognition (Donaldson et al. 2003 ; Martı́nezArán et al. 2005).”
BackgroundAssessing cognitive deficits in bipolar disorder: are self-reports valid?
Burdick, K. E., Endick, C. J., & Goldberg, J. F. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.12.009 · Cited by 157
“Cognitive deficits have been associated with lithium as well as a number of anticonvulsant drugs used to treat bipolar disorder (Goldberg and Burdick, 2001), although recent data suggest that standard mood stabilizers appear less likely than antipsychotic medications to impair memory and intellectual function in bipol…”
BackgroundPharmacological approaches in bipolar disorders and the impact on cognition: a critical overview
Dias, V. V., Balanzá‐Martinez, V., Soeiro‐de‐Souza, M. G., Moreno, R. A., Figueira, M. L., Machado‐Vieira, R., & Vieta, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01910.x · Cited by 146
“(105) 20 euthymic BD I and II Patients received Risperidone (n = 11) or conventional antipsychotics (n = 9).”
BackgroundNeurocognitive allied phenotypes for schizophrenia and bipolar disorder
Hill, S. K., Harris, M. S. H., Herbener, E. S., Pavuluri, M., & Sweeney, J. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn027 · Cited by 123
Toward the identification of neurocognitive subtypes in euthymic patients with bipolar disorder
Martino, D. J., Strejilevich, S. A., Marengo, E., Ibañez, A., Scápola, M., & Igoa, A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.059 · Cited by 75
“Likewise, this subgroup of patients might benefit from using with special caution or avoiding drugs with negative effect on cognition such as benzodiazepines or antipsychotics (Mintzer and Griffiths, 2003; Donaldson et al., 2003; Frangou et al., 2005).”
BackgroundDopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis
Szmulewicz, A. G., Angriman, F., Samamé, C., Ferraris, A., Vigo, D., & Strejilevich, S. A. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12712 · Cited by 37
“However, the use of these drugs is associated with a high burden of metabolic (10, 12), motor (10), emotional (13), and cognitive side-effects (14).”
BackgroundMedeiros, G. C., Lafer, B., Kapczinski, F., Miranda-Scippa, Â., & Almeida, K. M. (2018) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.12.003 · Cited by 23
Metadata
- Authors
- Donaldson, S., Goldstein, L. H., Landau, S., Raymont, V., & Frangou, S.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2003-01-15
- Volume
- 64
- Issue
- 1
- Pages
- 86-93
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W4323238079
- Cited by
- 112
- References
- 0
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.